No. S 323
Misuse of Drugs Act
(CHAPTER 185)
Misuse of Drugs Act
(Amendment of First, Fourth and Fifth
Schedules) Order 2014
In exercise of the powers conferred by sections 58A and 59 of the Misuse of Drugs Act, the Minister for Home Affairs hereby makes the following Order:
Citation and commencement
1.  This Order may be cited as the Misuse of Drugs Act (Amendment of First, Fourth and Fifth Schedules) Order 2014 and shall come into operation on 1st May 2014.
Amendment of First Schedule
2.  The First Schedule to the Misuse of Drugs Act is amended by deleting Part I and substituting the following Part:
Part I
CLASS A DRUGS
1.  The following substances and products:
(1)Acetorphine
(2)Acetylmethadol
(3)Allylprodine
(4)Alphacetylmethadol
(5)Alphameprodine
(6)Alphamethadol
(7)Alphaprodine
(8)2-Amino-1-(2,5-dimethoxy-4-methyl)phenylpropane
(9)Amphetamine
(10)Anileridine
(11)Benzethidine
(12)Benzylmorphine (3-benzylmorphine)
(13)1-Benzylpiperazine (also known as BZP)
(14)Betacetylmethadol
(15)Betameprodine
(16)Betamethadol
(17)Betaprodine
(18)Bezitramide
(19)4-Bromo-2,5-dimethoxy-α-methylphenethylamine (also known as Brolamfetamine or DOB)
(20)4-Bromo-2,5-dimethoxyphenethylamine (also known as 2C-B)
(21)Bufotenine
(22)Buprenorphine
(23)Cannabinol
(24)Cannabinol derivatives
(25)Cannabis and cannabis resin
(26)Cathinone
(27)Clonitazene
(28)Coca leaf
(29)Cocaine
(30)Codoxime
(31)4-Cyano-2-dimethylamino-4,4-diphenylbutane
(32)4-Cyano-1-methyl-4-phenyl-piperidine
(33)Desomorphine
(34)Dextromoramide
(35)Diamorphine
(36)Diampromide
(37)Diethylthiambutene
(38)N,N-Diethyltryptamine
(39)Difenoxin
(40)Dihydroetorphine
(41)Dihydromorphine
(42)Dimenoxadole
(43)Dimepheptanol
(44)2,5-Dimethoxy-4,α-dimethyl-phenethylamine
(45)2,5-Dimethoxy-α-methylphenethylamine
(46)N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine (also known as MDMA)
(47)3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
(48)Dimethylthiambutene
(49)N,N-Dimethyltryptamine
(50)Dioxaphetyl butyrate
(51)Diphenoxylate
(52)Dipipanone
(53)Drotebanol
(54)Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine
(55)4-Ethyl-2,5-dimethoxy-α-methylphenethylamine
(56)N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine (also known as MDEA)
(57)Ethylmethylthiambutene
(58)Eticyclidine
(59)Etonitazene
(60)Etorphine
(61)Etoxeridine
(62)Etryptamine
(63)Furethidine
(64)Gamma hydroxybutyric acid
(65)Hydrocodone
(66)Hydromorphinol
(67)Hydromorphone
(68)1-Hydroxy-3-pentyl-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6-H-dibenzo[b,d]pyran
(69)Hydroxypethidine
(70)Isomethadone
(71)Ketamine
(72)Ketobemidone
(73)Levomethorphan
(74)Levomoramide
(75)Levophenacylmorphan
(76)Levorphanol
(77)Lysergamide
(78)Lysergide and other N-alkyl derivatives of lysergamide
(79)Mescaline
(80)Metazocine
(81)Methadone
(82)Methadyl acetate
(83)Methamphetamine (also known as Methylamphetamine)
(84)5-Methoxy-N,N-diisopropyltryptamine
(85)3-Methoxy-α-methyl-4,5-(methylenedioxy)phenethylamine
(86)p-Methoxy-α-methylphenethylamine
(87)N-Methyl-α-ethyl-3,4-(methylenedioxy)phenethylamine (also known as MBDB)
(88)N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine
(89)α-Methyl-3,4-(methylenedioxy)phenethylamine (also known as Tenamfetamine or MDA)
(90)2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
(91)1-Methyl-4-phenylpiperidine-4-carboxylic acid
(92)4-Methylaminorex
(93)Methyldesorphine
(94)Methyldihydromorphine (6-Methyldihydromorphine)
(95)4-Methylthioamphetamine
(96)3-Methylthiofentanyl
(97)Metopon
(98)Monoacetylmorphine
(99)Morpheridine
(100)Morphine
(101)Morphine methobromide, morphine N-oxide and other pentavalent nitrogen morphine derivatives
(102)Myrophine
(103)Nicomorphine (3,6-dinicotinoyl-morphine)
(104)Noracymethadol
(105)Norbuprenorphine
(106)Norketamine and its dehydro derivatives
(107)Norlevorphanol
(108)Normethadone
(109)Normorphine
(110)Norpipanone
(111)Opium
(112)Oxycodone
(113)Oxymorphone
(114)Parahexyl (3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran)
(115)Pethidine
(116)Phenadoxone
(117)Phenampromide
(118)Phenazocine
(119)Phenomorphan
(120)Phenoperidine
(121)4-Phenylpiperidine-4-carboxylic acid ethyl ester
(122)Piminodine
(123)Piritramide
(124)Poppy-straw and concentrate of poppy-straw
(125)Proheptazine
(126)Properidine (1-Methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester)
(127)Psilocin
(128)Psilocybine
(129)Racemethorphan
(130)Racemoramide
(131)Racemorphan
(132)Remifentanil
(133)Rolicyclidine
(134)Tenocyclidine
(135)Thebacon
(136)Thebaine
(137)Tilidine
(138)1-(3-Trifluoromethylphenyl)piperazine (also known as TFMPP)
(139)Trimeperidine
(140)3,4,5-Trimethoxy-α-methylphenethylamine
2.  Any stereoisomeric form of a substance for the time being specified in paragraph 1, not being dextromethorphan or dextrorphan.
3.  Any ester or ether of a substance for the time being specified in paragraph 1 or 2, not being a substance for the time being specified in Part II.
4.  Any salt of a substance for the time being specified in any of paragraphs 1, 2 and 3.
5.  Any preparation or other products containing a substance or product for the time being specified in any of paragraphs 1 to 4.
6.  Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1, 2 and 3 of Part II.
7.  Fentanyl and any compounds structurally derived from N-(1-Methyl-4-piperidyl)-N-phenyl formamide by substitution of any of the hydrogen atoms, including the following; and any salt of any substance falling within this item:
(1)Alfentanil
(2)Alpha-methyl fentanyl
(3)Alpha-methyl fentanyl acetanilide
(4)Alpha-methylthiofentanyl
(5)Benzyl fentanyl
(6)Beta-hydroxy fentanyl
(7)Beta-hydroxy-3-methyl fentanyl
(8)Carfentanil
(9)Lofentanil
(10)3-Methyl fentanyl
(11)Para-fluorofentanyl
(12)Sufentanil
(13)Thiofentanyl
8.  Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)(1-Butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-073)
(2)(4-Chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-398)
(3)[1-(4-Chloropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as 4-Chloro-AM-2201)
(4)(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-210)
(5)[1-(5-Fluoropent-1-yl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone (also known as MAM-2201)
(6)[1-(5-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as AM-2201)
(7)[1-(4-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as 4-Fluoro-AM-2201)
(8)[1-(5-Fluoropent-1-yl)-6-nitro-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as AM-1235)
(9)[1-(Heptan-2-yl)-2-methyl-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as JWH-011)
(10)(1-Heptyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-020)
(11)(1-Hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-019)
(12)(4-Methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-081)
(13)(2-Methyl-1-propyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-015)
(14)(4-Methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-122)
(15){1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone (also known as AM-1220)
(16){1-[2-(Morpholin-4-yl)ethyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone (also known as JWH-200)
(17)Naphthalen-1-yl[1-(pent-4-en-1-yl)-1H-indol-3-yl]methanone (also known as JWH-022)
(18)Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-018)
(19)Naphthalen-1-yl(1-propyl-1H-indol-3-yl)methanone (also known as JWH-072)
9.  Any compound containing a 3-(1-naphthylmethyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)3-[(4-Methylnaphthalen-1-yl)methyl]-1-pentyl-1H-indole (also known as JWH-184)
(2)3-(Naphthalen-1-ylmethyl)-1-pentyl-1H-indole (also known as JWH-175)
10.  Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)[5-(2-Chlorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-369)
(2)[5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-307)
(3)[5-(3-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-368)
(4)(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-147)
(5)(1-Hexyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-031)
(6)[5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-370)
(7)Naphthalen-1-yl[5-(naphthalen-1-yl)-1-pentyl-1H-pyrrol-3-yl]methanone (also known as JWH-309)
(8)Naphthalen-1-yl(1-pentyl-5-phenyl-1H-pyrrol-3-yl)methanone (also known as JWH-145)
(9)Naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone (also known as JWH-030)
11.  Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)E-1-[1-(1-Naphthalenylmethylene)-1H-inden-3-yl]pentane (also known as JWH-176)
12.  Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)2-(2-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-203)
(2)1-[1-(2-Cyclohexylethyl)-1H-indol-3-yl]-2-(2-methoxyphenyl)ethanone (also known as RCS-8)
(3)2-(2-Methoxyphenyl)-1-{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}ethanone (also known as cannabipiperidiethanone)
(4)2-(2-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-250)
(5)2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-302)
(6)2-(4-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-201)
(7)2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-251)
13.  Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not substituted in the cyclohexyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)2-[5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol (also known as CP55,940)
(2)2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol (also known as CP47,497)
14.  Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)[1-(5-Fluoropentyl)-1H-indol-3-yl](2-iodophenyl)methanone (also known as AM-694)
(2)(2-Iodo-5-nitrophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-1241)
(3)(2-Iodophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-2233)
(4)(2-Iodophenyl)(1-pentyl-1H-indol-3-yl)methanone (also known as AM-679)
(5)(4-Methoxyphenyl){2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone (also known as pravadoline)
(6)(4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone (also known as RCS-4)
15.  Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)Adamantan-1-yl{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-1248)
(2)Adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone (also known as AB-001)
16.  Any compound, other than bupropion, that is structurally derived from 2-amino-1-phenylpropan-1-one by modification in any of the following ways:
(a)substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(b)substitution at the 3-position with an alkyl substituent;
(c)substitution at the nitrogen atom with alkyl or dialkyl, benzyl or methoxybenzyl groups, or by inclusion of the nitrogen atom in a cyclic structure,
including any salt or stereoisomeric form of the above compounds, and any preparation or product containing the above compounds, for example:
(1)1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-propanone (also known as Bk-MDDMA)
(2)1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one (also known as ethylone)
(3)1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one (also known as butylone)
(4)1-(1,3-Benzodioxol-5-yl)-2-(methylamino)pentan-1-one (also known as pentylone)
(5)1-(1,3-Benzodioxol-5-yl)-2-(methylamino)propan-1-one (also known as methylone or 3,4-methylenedioxy-N-methylcathinone)
(6)1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one (also known as MDPBP)
(7)1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as 3,4-methylenedioxypyrovalerone or MDPV)
(8)1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one (also known as MDPPP)
(9)2-(Dimethylamino)-1-phenylpropan-1-one (also known as metamfepramone or dimethylcathinone)
(10)1-(Dimethylphenyl)-2-(methylamino)propan-1-one (also known as dimethylmethcathinone)
(11)2-(Ethylamino)-1-(methylphenyl)propan-1-one (also known as methylethcathinone)
(12)2-(Ethylamino)-1-phenylbutan-1-one (also known as N-ethylbuphedrone)
(13)2-(Ethylamino)-1-phenylpentan-1-one (also known as α-Ethylaminopentiophenone)
(14)2-(Ethylamino)-1-phenylpropan-1-one (also known as ethcathinone)
(15)1-(Fluorophenyl)-2-(methylamino)propan-1-one (also known as fluoromethcathinone)
(16)1-(Methoxyphenyl)-2-(methylamino)propan-1-one (also known as methoxymethcathinone)
(17)1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)propan-1-one (also known as MOPPP)
(18)2-(Methylamino)-1-phenylbutan-1-one (also known as buphedrone)
(19)2-(Methylamino)-1-phenylpentan-1-one (also known as pentedrone)
(20)2-(Methylamino)-1-phenylpropan-1-one (also known as methcathinone)
(21)1-(Methylphenyl)-2-(methylamino)propan-1-one (also known as methylmethcathinone)
(22)1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)butan-1-one (also known as MPBP)
(23)1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as pyrovalerone)
(24)1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one (also known as α-PBP)
(25)1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one (also known as α-PVP)
(26)1-Phenyl-2-(pyrrolidin-1-yl)propan-1-one (also known as α-PPP)
17.  Any compound that is structurally derived from 2-aminopropan-1-one by substitution at the 1-position with any monocyclic, or fused-polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways:
(a)substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
(b)substitution at the 3-position with an alkyl substituent; or
(c)substitution at the 2-amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure,
including any salt or stereoisomeric form of the above compounds, and any preparation or product containing the above compounds, for example:
(1)1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as naphyrone or naphthylpyrovalerone)
(2)2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one (also known as α-Pyrrolidinopentiothiophenone or α-PVT)
18.  The following compounds, including any salt or stereoisomeric form of such compounds, and any preparation or product containing such compounds:
(1)N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (also known as APINACA)
(2)N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide (also known as APICA)
(3)5-(2-Aminopropyl)benzofuran (also known as 5-APB)
(4)6-(2-Aminopropyl)benzofuran (also known as 6-APB or BenzoFury)
(5)5-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 5-APDB)
(6)6-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 6-APDB)
(7)17-Carboxy-16,17-dihydromitragynine
(8)16-Carboxymitragynine
(9)17-O-Desmethyl-16,17-dihydromitragynine
(10)9-O-Desmethylmitragynine
(11)2,3-Dihydro-1H-inden-2-amine (also known as 2-Aminoindane)
(12)6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (also known as 5,6-(methylenedioxy)-2-aminoindane or MDAI)
(13)2,3-Dihydro-5-iodo-1H-inden-2-amine (also known as 5-Iodo-2-aminoindane or 5-IAI)
(14)[2,3-Dihydro-5-methyl-3-(morpholin-4-ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl](naphthalen-1-yl)methanone
(15){4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-yl}methanol
(16)6,6-Dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1,9-diol
(17)N,N-Dimethyl-1-phenylpropan-2-amine (also known as N,N-dimethylamphetamine)
(18)Diphenyl(pyrrolidin-2-yl)methanol (also known as diphenylprolinol)
(19)2-Diphenylmethylpiperidine (also known as desoxypipradrol)
(20)[1-(5-Fluoropent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as XLR-11 or 5-fluoro UR-144)
(21)1-(Fluorophenyl)piperazine
(22)1-(Fluorophenyl)propan-2-amine
(23)1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6,6a,7,8,10,10a-hexahydro-9H-benzo[c]chromen-9-one
(24)[9-Hydroxy-6-methyl-3-(5-phenylpentan-2-yl)oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate
(25)3-Hydroxy-2-[3-methyl-6-(2-propenyl)-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone
(26)9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
(27)7-Hydroxymitragynine
(28)2-(3-Methoxyphenyl)-2-(N-ethylamino)cyclohexanone (also known as methoxetamine)
(29)N-Methyl-1-(fluorophenyl)propan-2-amine
(30)N-Methyl-1-(methoxyphenyl)propan-2-amine
(31)N-Methyl-1-(methylphenyl)propan-2-amine
(32)(N-Methyl-4-phenylpiperidin-4-yl)propanoate (also known as desmethylprodine)
(33)N-Methyl-1-(thiophen-2-yl)propan-2-amine (also known as methiopropamine)
(34)1-(4-Methylbenzo-1,3-dioxol-6-yl)propan-2-amine (also known as 5-methyl-MDA or 5-methyl-3,4-methylenedioxyamphetamine)
(35)Mitragynine
(36)Naphthalen-1-yl(4-pentyloxynaphthalen-1-yl)methanone (also known as CB-13)
(37)5-[3-(1-Naphthoyl)-1H-indol-1-yl]pentanenitrile (also known as AM-2232)
(38)(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (also known as UR-144)
(39)Salvinorin A”.
Amendment of Fourth Schedule
3.  The Fourth Schedule to the Misuse of Drugs Act is amended —
(a)by deleting item 2 and substituting the following item:
2.N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine (also known as MDMA)”;
(b)by deleting item 4 and substituting the following item:
4.N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine (also known as MDEA)”; and
(c)by inserting, immediately after the word “Tenamfetamine” in item 7, the words “or MDA”.
Deletion and substitution of Fifth Schedule
4.  The Fifth Schedule to the Misuse of Drugs Act is deleted and the following Schedule substituted therefor:
FIFTH SCHEDULE
Sections 24, 26, 27, 32 and 58A
Temporarily listed drugs
1.The following compounds, including any salt or stereoisomeric form of such compounds, and any preparation or product containing such compounds:
(1)N-(1-Adamantyl)-5-fluoropentyl-1H-indazole-3-carboxamide (also known as 5-Fluoro-APINACA or 5F-AKB48)
(2)N-(1-Adamantyl)-5-fluoropentyl-1H-indole-3-carboxamide (also known as 5-Fluoro-APICA or STS-135)
(3)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as AB-FUBINACA)
(4)4-(2-Aminopropyl)benzofuran (also known as 4-APB)
(5)7-(2-Aminopropyl)benzofuran (also known as 7-APB)
(6)4-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 4-APDB)
(7)7-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 7-APDB)
(8)2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25B-NBOMe)
(9)2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25C-NBOMe)
(10)2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25H-NBOMe)
(11)2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25I-NBOMe)
(12)Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (also known as 5-Fluoro-PB-22 or 5-Fluoro-QUPIC)
(13)Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (also known as PB-22 or QUPIC)”.
Made this 29th day of April 2014.
TAN TEE HOW
Permanent Secretary,
Ministry of Home Affairs,
Singapore.
[MHA 112/2/0049; AG/LLRD/SL/185/2010/8 Vol. 1]